Global High-Throughput Screening Market to Grow at a CAGR of 7.82% by 2030

The global high-throughput screening market size was worth around USD 18.93 Billion in 2021 and is projected to grow around USD 36.84 Billion by 2030, with a compounded annual growth rate of (CAGR) of roughly 7.82% from 2022 to 2030.

High-throughput screening (HTS) is a procedure for undertaking scientific experimentation in the drug discovery & development process and is relevant to the areas of materials science, biology, and chemistry. With the help of data processing, robotics, sensitive detectors, and liquid handling devices, high-throughput screening facilitates researchers to rapidly initiate and manage millions of genetic, chemical, or pharmacological tests. These processes can efficiently help people to swiftly determine antibodies, active compounds, or genes that regulate specific biomolecular pathways. The intrinsic results achieved from these distinctive experiments derive the emerging points and basis for the necessary drug design & development process and also for comprehending the noninteraction or contribution of a particular location.

The demand in the global high-throughput screening market is expected to surge due to an increase in the geriatric population in various countries around the globe, the adoption of a sedentary lifestyle among millennials, growing investment in healthcare, growth in research & development activities, persistent technological launches of advanced products that are abridged & automated, and increase in the prevalence of high-throughput screening for drug discovery & development procedures further drive the growth of the global high-throughput screening market during the forecast period. In addition, rapid adoption and acceptance of pioneering high-throughput screening among biotechnology and pharmaceutical companies around the world are augmenting the growth of the market.

Exponential growth in economies of emerging countries and expansion of rigorous research and development activities on toxicology stem cells is further predicted to offer remunerative opportunities for the prominent manufacturers of high-throughput screening products in the near future. However, the extortionate cost of high-throughput screening, unavailability of skilled professionals, and adverse apprehensions in assay development restrict the growth of the global market to an extent.

The global high-throughput screening market is segmented based on product and service, technology, application, end-user, and region.

Based on product and service, the global market is bifurcated into reagents & assay kits, instruments, consumables & accessories, software, and services. The consumables segment held the largest market share in 2021 and is further expected to grow at a significant compound annual growth rate (CAGR) during the forecast period. The sizeable market share of this segment is mainly attributed to the increase in investment in pharmaceutical research and development. In addition, growing awareness and prevalence of government support towards various life science projects and research further drive the growth of the segment during the forecast period.

Based on end-user, the global market is bifurcated into pharmaceutical and biotechnology industries, contract research organizations, academic and government institutes, and others. The academic and government institutes segment is projected to grow at a significant CAGR during the forecast period. The major reason for the growth of this segment is mainly due to an increase in awareness and knowledge about innovative technologies and drug discovery techniques in academic and government institutes. Besides, when drug development procedures take place, academic institutions are known for conducting validation research and target decision. This drives the growth of the segment.

Geographically, in the global high-throughput screening market, the North American market accounted for the highest share and is expected to continue this pattern during the forecast period. This is mainly due to its increased awareness, rising government funding, entrenched and ever-growing healthcare industry, and seamless availability of advanced technologies due to technological awareness and innovation in the region. There has been a remarkable increase in R&D activities that drive the growth of the market in this region. Apart from that, the growing prevalence of chronic diseases drives the need for novel treatments that in turn, augment the growth of the market in this region.

This review is based on a report by Zion Market Research, titled “High-Throughput Screening Market By Product And Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services), By Technology (Cell-Based Assays, Lab-On-A-Chip, Label-Free, 2D Cell Culture, 3D Cell Culture, and Bioinformatics), By Application (Target Identification and Validation, Drug Discovery, Primary and Secondary Screening, Toxicology Assessment, and Others), By End User (Pharmaceutical and Biotechnology Industries, Contract Research Organizations, Academic and Government Institutes, and Others) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2030.”- Report at https://www.zionmarketresearch.com/report/high-throughput-screening-market

Recent Developments:

• In November 2022, Particle Works, an innovative company that designs and manufactures innovative particle engineering platforms, announced the launch of its new pioneering platform called the Automated Library Synthesis (ALiS) System. This creative platform favors high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates and automation in the primal stages of drug development. The futuristic ALiS platform is based on microfluidic technology and provides a number of distinctive perks. One of the most prominent benefits is that the software of ALiS platform facilitates walk-away processing of up to 96 unique formulations in an average working day, originating from and bestowing upon covered 96 well plates.
• In April 2022, Twist Bioscience Corporation, a California-based company, announced the launch of its gene-to-antibody production platform called the Twist High Throughput Antibody Production, which helps customers to turn candidate DNA sequences into purified antibodies for numerous screening applications and undertaking therapeutic discoveries.

The global high-throughput screening market is dominated by players such as:

• Agilent Technologies Inc
• Danaher Corporation
• Perkinelmer Inc. 
• Thermo Fisher Scientific Inc
• Axxam S.P.A
• Tecan Group Ltd
• Bio-Rad Laboratories Inc.
• Hamilton Company
• Sigma-Aldrich Corporation
• Charles River Laboratories International Inc.
• Merck KGaA
• Corning Incorporated
• BioTek Instruments Inc.
• Aurora Biomed Inc.
• General Electric
• Beckman Coulter Inc.
• Luminex Corporation
• AstraZeneca

The global high-throughput screening (HTS) market is segmented as follows:

By Application

• Target Identification and Validation
• Drug Discovery
• Primary and Secondary Screening
• Toxicology Assessment

By Technology

• Cell-Based Assays
• Lab-On-A-Chip
• Label-Free
• 2D Cell Culture
• 3D Cell Culture
• Bioinformatics

By Product and Service

• Reagents & Assay Kits,
• Instruments,
• Consumables & Accessories
• Software
• Services

By End User

• Pharmaceutical and Biotechnology Industries
• Contract Research Organizations
• Academic and Government Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com